FDA Checks Indian Drug Plants
No major deficiency found during inspection of Ranbaxy, Orchid, Emcure, Nectar & Ind Swift Facilities
The US drug regulator has inspected manufacturing plants of at least half a dozen Indian drugmakers in the last few weeks, raising hopes among some of these companies that they will shortly be able to export medicines to the world's largest drug market.
Several industry executives said teams o
Publication Date:
05/07/2011